23.81
1.49%
+0.35
アフターアワーズ:
23.82
0.01
+0.04%
Artivion Inc (AORT) 最新ニュース
Shareholders in Artivion (NYSE:AORT) are in the red if they invested a year ago - Yahoo New Zealand News
Yahoo New Zealand News
Artivion executive sells shares worth over $29k By Investing.com - Investing.com
Investing.com
Artivion executive sells $23,285 in company stock By Investing.com - Investing.com
Investing.com
Artivion executive sells $23,285 in company stock - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Artivion, Inc. (NYSE:AORT) SVP Sells $23,290.41 in Stock - MarketBeat
MarketBeat
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? - Zacks Investment Research
Zacks Investment Research
Stifel Nicolaus Increases Artivion (NYSE:AORT) Price Target to $25.00 - Defense World
Defense World
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Yahoo Finance
Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher - Simply Wall St
Simply Wall St
Artivion (NYSE:AORT) PT Raised to $30.00 at Needham & Company LLC - Defense World
Defense World
Zurcher Kantonalbank Zurich Cantonalbank Buys 2108 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Defense World
Artivion stock price target raised on revenue growth - Investing.com Nigeria
Investing.com Nigeria
Artivion (NYSE:AORT) Price Target Increased to $25.00 by Analysts at Stifel Nicolaus - MarketBeat
MarketBeat
Artivion (NYSE:AORT) Reaches New 52-Week High Following Earnings Beat - MarketBeat
MarketBeat
Artivion stock price target raised on revenue growth - Investing.com
Investing.com
Artivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Artivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Breaking Down Artivion: 4 Analysts Share Their Views - Artivion (NYSE:AORT) - Benzinga
Benzinga
Artivion: Q1 Earnings Snapshot - Milford Mirror
Milford Mirror
Artivion (NYSE:AORT) Reaches New 52-Week High Following Earnings Beat - MarketBeat
MarketBeat
Artivion: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Is Artivion (AORT) Outperforming Other Medical Stocks This Year? - Yahoo Canada Shine On
Yahoo Canada Shine On
Artivion Inc (AORT) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance - Yahoo Finance
Yahoo Finance
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research
Artivion earnings beat by $0.18, revenue topped estimates - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Artivion Reports First Quarter 2024 Financial Results - PR Newswire
PR Newswire
Artivion: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Artivion presents double win at AATS for aortic devices - Clinical Trials Arena
Clinical Trials Arena
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American ... - Citizentribune
Citizentribune
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American ... - PR Newswire
PR Newswire
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year - Yahoo
Yahoo
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference - PR Newswire
PR Newswire
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?
Zacks Investment Research
Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Yahoo Finance
Are Medical Stocks Lagging Artivion (AORT) This Year?
Zacks Investment Research
Are Medical Stocks Lagging Artivion (AORT) This Year? - Yahoo
Yahoo
3 Buy-Rated Small Caps Flexing Big Growth
Zacks Investment Research
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
Zacks Investment Research
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? - Yahoo
Yahoo
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - PR Newswire
PR Newswire
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
Zacks Investment Research
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Zacks Investment Research
Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet
Zacks Investment Research
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
Benzinga
Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):